BioViva’s Liz Parrish makes progress in controversial gene quest to reverse aging

Last fall, the 45-year-old Seattle-area woman underwent an experimental type of gene therapy aimed at addressing some of the big effects of aging, including loss of muscle mass and a shortening of the chromosomes’ telomeres.

“Over 100,000 people die every day of aging diseases,” she said. “Somebody told me today, they said, ‘You’re so brave.’ Maybe I am, maybe I’m not. What’s brave is knowing that there could be a cure for aging diseases, and not taking it, and deciding that you’re going to wither away. I’m not that brave.”